Hypertension and central obesity are two conditions closely linked, bu
t the mechanisms responsible for obesity-associated hypertension are s
till unclear. In the last few years, several studies addressed the rol
e of endothelin-1 (ET-1) in the development and maintenance of hyperte
nsion. This study was designed to evaluate plasma ET-1 in normotensive
and hypertensive central obese subjects compared with a lean healthy
group. Our final goal was to analyze the relationship between plasma E
T-1, blood pressure, and left ventricular structure and function in ce
ntral obese subjects (both normotensives and hypertensives). ET-levels
have been assessed by the radioimmunoassay method in 20 lean normoten
sives and in 57 central obese subjects; 30 of them were hypertensives
and 27 of them were normotensives. Twenty-four-hour mean blood pressur
e (MBP/24 h) by noninvasive ambulatory blood pressure monitoring, left
ventricular mass/ height (LVM/H), and left ventricular ejection fract
ion (LVEF) by echocardiography and peak filling rate (PFR) by radionuc
lide study were also measured. ET levels were significantly (P <.05) h
igher in obese hypertensives and obese normotensives than in lean norm
otensives. In addition, ET levels were significantly (P <.05) higher i
n obese hypertensives than in obese normotensives. ET were directly re
lated to LVM/H (r = 0.86; P <.001) and MBP/24 h (r = 0.48; P <.009) bu
t only in obese hypertensives. Multiple regression analysis indicated
that ET-1 plasma levels remain an independent predictor of MBP/24 h an
d LVM/H also when age was included in the analysis. These data suggest
that obesity-associated hypertension is characterized by an endotheli
al dysfunction that may contribute to the higher cardiovascular risk d
etectable in these patients. (C) 1996 American Journal of Hypertension
, Ltd.